Timing delivery with a blood test for severe preeclampsia
Part of Women’s health & pregnancy clinical trials.
This trial is testing whether a blood test measuring certain proteins (sFlt-1 and PlGF) can help doctors decide the best time to deliver the baby for women with severe early-onset preeclampsia. The goal is to improve outcomes for both mother and baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You are pregnant with one baby (not twins or more).
- You have been diagnosed with severe preeclampsia (a serious pregnancy condition with high blood pressure and organ stress).
- Your pregnancy is between 30 weeks and 33 weeks and 6 days, based on an early ultrasound.
- Your baby does not have major birth defects or a confirmed genetic syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for genes that may be linked to severe preeclampsia, a serious blood pressure condition in pregnancy. It compares women with severe preeclampsia to those with healthy pregnancies to understand why it happens.
This study tests whether measuring certain proteins in the blood (angiogenic factors) can help doctors better manage preeclampsia in women who are 36 to 38 weeks pregnant. The goal is to see if this approach can safely delay delivery and improve outcomes for both mother and baby.
This trial tests whether measuring two pregnancy blood markers (sFlt1 and PlGF) and planning delivery timing can help prevent preeclampsia as you reach term. It may help reduce risk for mother and baby by guiding when to deliver based on test results.
This trial tests a new medicine, CBP-4888, for pregnant women hospitalized with preeclampsia starting after 20 weeks. The goal is to see if it's safe and how it works for you and your baby, who will be followed for up to 24 months after birth.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This study is for pregnant women to check their risk of pre-eclampsia (a serious condition causing high blood pressure) using simple tests like blood work or ultrasound. It aims to help you and your doctor manage your pregnancy better.
Hear when a new Severe Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.